Harrow (HROW) Amortizatization of Intangibles (2015 - 2021)
Harrow's (HROW) quarterly Amortizatization of Intangibles came in at $123000.0 in Q3 2021, down 41.15% year-on-year from $209000.0 in Q3 2020, and down 18.54% quarter-over-quarter from $151000.0 in Q2 2021.
Harrow (HROW) Amortizatization of Intangibles (2015 - 2021) Analysis & Trends
Harrow's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $123000.0 for Q3 2021.
- On a quarterly basis, Amortizatization of Intangibles fell 41.15% year-over-year to $123000.0 in Q3 2021; TTM through Sep 2021 was $568000.0, a 16.72% decrease from a year earlier, with the FY2020 full-year figure at $696000.0, up 34.36% from the prior year.
- Amortizatization of Intangibles fell to $123000.0 in Q3 2021 per HROW's latest filing, from $151000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $336000.0 in Q1 2017 and bottomed at $123000.0 in Q3 2021.
- The 4-year median for Amortizatization of Intangibles is $148000.0 (2021), against an average of $168666.7.
- Across the five-year window, Amortizatization of Intangibles tumbled 82.99% in 2017 and surged 60.77% in 2020, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $166000.0 in 2017, then retreated by 20.48% to $132000.0 in 2019, then climbed by 10.61% to $146000.0 in 2020, then slipped by 15.75% to $123000.0 in 2021.
- Per Business Quant, the three latest HROW Amortizatization of Intangibles figures stand at $123000.0 (Q3 2021), $151000.0 (Q2 2021), and $148000.0 (Q1 2021).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 27.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 123,000.00 |
| Sep 30, 2021 | 123,000.00 |
| Jun 30, 2021 | 151,000.00 |
| Jun 30, 2021 | 151,000.00 |
| Mar 31, 2021 | 148,000.00 |
| Mar 31, 2021 | 148,000.00 |
| Dec 31, 2020 | 146,000.00 |
| Dec 31, 2020 | 146,000.00 |
| Sep 30, 2020 | 209,000.00 |
| Sep 30, 2020 | 209,000.00 |
| Jun 30, 2020 | 172,000.00 |
| Jun 30, 2020 | 172,000.00 |
| Mar 31, 2020 | 169,000.00 |
| Mar 31, 2020 | 169,000.00 |
| Dec 31, 2019 | 132,000.00 |
| Dec 31, 2019 | 132,000.00 |
| Sep 30, 2019 | 130,000.00 |
| Sep 30, 2019 | 130,000.00 |
| Jun 30, 2019 | 126,000.00 |
| Jun 30, 2019 | 126,000.00 |